首页 | 本学科首页   官方微博 | 高级检索  
检索        

吡嘧司特钾联合西替利嗪治疗慢性荨麻疹疗效观察
引用本文:陈雷,朱清娟,王启华.吡嘧司特钾联合西替利嗪治疗慢性荨麻疹疗效观察[J].山东医学高等专科学校学报,2014(5):386-388.
作者姓名:陈雷  朱清娟  王启华
作者单位:1. 郯城县第一人民医院,山东临沂,276100
2. 临沂市皮肤病医院
基金项目:临沂市科技发展计划项目
摘    要:目的观察西替利嗪联合吡嘧司特钾治疗慢性荨麻疹的治疗效果。方法将慢性荨麻疹患者90例随机分为治疗组和对照组各45例,治疗组采用西替利嗪片联合吡嘧司特钾片治疗,对照组则只服用西替利嗪治疗。结果治疗组的有效率为88.9%,明显高于对照组71.1%,两组对比有显著性差异(P〈0.05)。结论西替利嗪联合吡嘧司特钾治疗慢性荨麻疹具有较好的疗效,值得临床推广应用。

关 键 词:西替利嗪  吡嘧司特钾  荨麻疹

THE CURATIVE EFFECT OF THE COMBINED USE OF PEMIROLAST POTASSIUM AND CETIRIZINE ON CHRONIC URTICARIA
CHEN Lei,ZHU Qing-juan,WANG Qi-hua.THE CURATIVE EFFECT OF THE COMBINED USE OF PEMIROLAST POTASSIUM AND CETIRIZINE ON CHRONIC URTICARIA[J].Journal of Shandong Medical College,2014(5):386-388.
Authors:CHEN Lei  ZHU Qing-juan  WANG Qi-hua
Institution:CHEN Lei , ZHU Qing-juan , WANG Qi-hua (Tancheng County NO. 1 People's Hospital, Linyi, China 276100)
Abstract:Objective To observe the curative effect of the combined use of pemirolast potassium and cetirizine on chronic urticaria. Methods 90 cases of chronic urticaria were randomly divided into the treatment and the contrast groups. The 45 cases in the treatment group were treated with the combined use of pemirolast potassium and cetirizine, while the 45 eases in the cont-ast group were treated only with cetirizine. Results The curative rates in the treatment group and the con trast group were 88.9% and 71.1% respectively( P 〈0.05). Conclusion The combined use of pemirolast potassium and cetirizine can produce good curative effects on chronic urticaria.
Keywords:Cetirizine  Pemirolast potassium  Urticaria
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号